EUVIMEDEUVIMED entdecken
Crossref

Adenylyl Cyclase Activator: Forskolin Mediates CREB ser133 Phosphorylation in the Hippocampus, Alleviates Autism‐Like Deficits in a Valproic Acid Model of Wistar Rats

Ashish Jain iD, Neha Dhir, Praisy K Prabha, Anupam Raja, Amit Raj Sharma, Tamanna Kaundal, Shiv Charan, Alka Bhatia, Dibyajyoti Banerjee, Biman Saikia, Deepy Zohmangaihi, Manoj K Goyal und 2 weitere

Journal of Neuroscience Research · 2025

DOI: 10.1002/jnr.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroscience Research, 2025. Verfasst von Ashish Jain und 13 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Pharmacology Laboratory (EPL), Neurobehavioral Research Laboratory (NBRL), Department of Pharmacology, Postgraduate Institute of Medical…. Hauptthemen laut MEDLINE: Hippocampus, Colforsin, Cyclic AMP Response Element-Binding Protein, Autism Spectrum Disorder. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by social deficits, restricted interest, and repetitive behaviors. The prevalence is higher in males (4:1). FDA‐approved drugs, Aripiprazole, and risperidone, only target comorbid conditions and have significant side effects. Dysregulation in cAMP‐responsive element‐binding protein (CREB) signaling is reported in autistic individuals. Forskolin is traditionally used in Ayurvedic medicine with lesser side effects. It is a potent adenylyl cyclase (AC) activator, increases intracellular cyclic adenosine monophosphate (cAMP) levels, thereby activating the protein kinase A (PKA)/CREB pathway with clinically proven benefits as an anticancer, anti‐asthmatic, and in metabolic disorder, and crosses the blood–brain‐barrier (BBB) junction. The present study aimed to investigate the impact of Forskolin and sought to explore the role of estrogen beta (ERβ/ESR2) receptors in a valproic acid (VPA) model of ASD. Pregnant Wistar rats received VPA or an equal volume of saline on gestational day (GD) 12.5. From postnatal day (PND) 23, male and female rats were divided separately into control, VPA, risperidone, and Forskolin (10–30 mg/kg) groups. Systemic administration of Forskolin ameliorated anxiety, social deficit, repetitive behavior, spatial recognition memory, motor coordination, gastrointestinal (GIT) motility, brain edema, and BBB permeability in a dose‐dependent manner. Moreover, chronic Forskolin treatment significantly alleviated VPA‐induced neuronal damage in the prefrontal cortex (PFC), hippocampus (HC), and cerebellum, and increased the intracellular CREB ser133 protein phosphorylation. Forskolin upregulated the mRNA expression of CREB signaling, which was altered by prenatal VPA administration. Our findings indicate that Forskolin provides neuroprotection through CREB signaling, suggesting its therapeutic potential for ASD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusColforsinCyclic AMP Response Element-Binding ProteinAutism Spectrum DisorderAutistic DisorderAnimalsRats, WistarValproic AcidRatsMaleFemalePhosphorylationPregnancyDisease Models, AnimalAdenylyl CyclasesPrenatal Exposure Delayed Effects

Stichwörter der Autor:innen

CREB ser133ForskolinWistar ratsadenylyl cyclaseautism spectrum disorderneuroprotectionvalproic acid

Substanzen

Valproic AcidColforsinCyclic AMP Response Element-Binding ProteinAdenylyl CyclasesCreb1 protein, rat

Autor:innen und Institutionen

  • Experimental Pharmacology Laboratory (EPL), Neurobehavioral Research Laboratory (NBRL), Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Neurology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Biochemistry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

ORCID-Profile: Ashish Jain, Bikash Medhi, Ajay Prakash

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Jain, A., Dhir, N., Prabha, P. K., Raja, A., Sharma, A. R., Kaundal, T., Charan, S., Bhatia, A., Banerjee, D., Saikia, B., Zohmangaihi, D., Goyal, M. K., Medhi, B., & Prakash, A. (2025). Adenylyl Cyclase Activator: Forskolin Mediates CREB ser133 Phosphorylation in the Hippocampus, Alleviates Autism‐Like Deficits in a Valproic Acid Model of Wistar Rats. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.70049

Vancouver

Jain A, Dhir N, Prabha PK, Raja A, Sharma AR, Kaundal T, et al. Adenylyl Cyclase Activator: Forskolin Mediates CREB ser133 Phosphorylation in the Hippocampus, Alleviates Autism‐Like Deficits in a Valproic Acid Model of Wistar Rats. Journal of Neuroscience Research. 2025. doi:10.1002/jnr.70049

BibTeX
@article{Jain2025,
  author = {Jain, Ashish and Dhir, Neha and Prabha, Praisy K and Raja, Anupam and Sharma, Amit Raj and Kaundal, Tamanna and Charan, Shiv and Bhatia, Alka and Banerjee, Dibyajyoti and Saikia, Biman and Zohmangaihi, Deepy and Goyal, Manoj K and Medhi, Bikash and Prakash, Ajay},
  title = {Adenylyl Cyclase Activator: Forskolin Mediates CREB ser133 Phosphorylation in the Hippocampus, Alleviates Autism‐Like Deficits in a Valproic Acid Model of Wistar Rats},
  journal = {Journal of Neuroscience Research},
  year = {2025},
  doi = {10.1002/jnr.70049}
}
Kostenlos starten →